nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—ABCB1—kidney cancer	0.109	1	CbGaD
Risperidone—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0439	0.0778	CbGbCtD
Risperidone—CYP3A7—Temsirolimus—kidney cancer	0.0439	0.0778	CbGbCtD
Risperidone—CYP3A5—Temsirolimus—kidney cancer	0.0329	0.0583	CbGbCtD
Risperidone—HTR2B—Sorafenib—kidney cancer	0.0315	0.0559	CbGbCtD
Risperidone—ABCB1—Temsirolimus—kidney cancer	0.0214	0.038	CbGbCtD
Risperidone—KCNH2—Sunitinib—kidney cancer	0.0212	0.0376	CbGbCtD
Risperidone—HTR2C—Sorafenib—kidney cancer	0.0205	0.0364	CbGbCtD
Risperidone—CYP2D6—Temsirolimus—kidney cancer	0.0202	0.0358	CbGbCtD
Risperidone—CYP3A4—Everolimus—kidney cancer	0.019	0.0337	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0151	0.0267	CbGbCtD
Risperidone—CYP3A7—Paclitaxel—kidney cancer	0.0151	0.0267	CbGbCtD
Risperidone—CYP3A7—Sorafenib—kidney cancer	0.0134	0.0237	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0134	0.0237	CbGbCtD
Risperidone—CYP3A7—Vincristine—kidney cancer	0.013	0.023	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.013	0.023	CbGbCtD
Risperidone—CYP3A4—Temsirolimus—kidney cancer	0.0128	0.0228	CbGbCtD
Risperidone—CYP3A5—Erlotinib—kidney cancer	0.0123	0.0219	CbGbCtD
Risperidone—CYP3A5—Paclitaxel—kidney cancer	0.0113	0.02	CbGbCtD
Risperidone—ABCB1—Pazopanib—kidney cancer	0.0113	0.0199	CbGbCtD
Risperidone—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0108	0.0192	CbGbCtD
Risperidone—CYP3A7—Sunitinib—kidney cancer	0.0108	0.0192	CbGbCtD
Risperidone—CYP2D6—Pazopanib—kidney cancer	0.0106	0.0188	CbGbCtD
Risperidone—ABCB1—Dactinomycin—kidney cancer	0.0103	0.0182	CbGbCtD
Risperidone—CYP3A5—Sorafenib—kidney cancer	0.01	0.0178	CbGbCtD
Risperidone—CYP3A5—Vincristine—kidney cancer	0.00974	0.0173	CbGbCtD
Risperidone—ABCB1—Gemcitabine—kidney cancer	0.00814	0.0144	CbGbCtD
Risperidone—CYP3A5—Sunitinib—kidney cancer	0.00813	0.0144	CbGbCtD
Risperidone—ABCB1—Erlotinib—kidney cancer	0.00803	0.0142	CbGbCtD
Risperidone—CYP2D6—Erlotinib—kidney cancer	0.00757	0.0134	CbGbCtD
Risperidone—ABCB1—Paclitaxel—kidney cancer	0.00735	0.013	CbGbCtD
Risperidone—CYP3A4—Pazopanib—kidney cancer	0.00675	0.012	CbGbCtD
Risperidone—ABCB1—Sorafenib—kidney cancer	0.00653	0.0116	CbGbCtD
Risperidone—ABCB1—Vinblastine—kidney cancer	0.00645	0.0114	CbGbCtD
Risperidone—ABCB1—Vincristine—kidney cancer	0.00634	0.0112	CbGbCtD
Risperidone—CYP2D6—Sorafenib—kidney cancer	0.00616	0.0109	CbGbCtD
Risperidone—CYP2D6—Vinblastine—kidney cancer	0.00608	0.0108	CbGbCtD
Risperidone—ABCB1—Sunitinib—kidney cancer	0.00529	0.00938	CbGbCtD
Risperidone—CYP3A4—Erlotinib—kidney cancer	0.00481	0.00853	CbGbCtD
Risperidone—CYP3A4—Paclitaxel—kidney cancer	0.00441	0.00781	CbGbCtD
Risperidone—ABCB1—Doxorubicin—kidney cancer	0.00396	0.00702	CbGbCtD
Risperidone—CYP3A4—Sorafenib—kidney cancer	0.00391	0.00693	CbGbCtD
Risperidone—CYP3A4—Vinblastine—kidney cancer	0.00386	0.00685	CbGbCtD
Risperidone—CYP3A4—Vincristine—kidney cancer	0.0038	0.00673	CbGbCtD
Risperidone—CYP2D6—Doxorubicin—kidney cancer	0.00373	0.00662	CbGbCtD
Risperidone—CYP3A4—Sunitinib—kidney cancer	0.00317	0.00562	CbGbCtD
Risperidone—CYP3A4—Doxorubicin—kidney cancer	0.00237	0.00421	CbGbCtD
Risperidone—HTR2A—urine—kidney cancer	0.00123	0.0527	CbGeAlD
Risperidone—CYP3A4—urine—kidney cancer	0.00113	0.0488	CbGeAlD
Risperidone—CYP2D6—urine—kidney cancer	0.00112	0.048	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000983	0.0422	CbGeAlD
Risperidone—H1F0—nephron tubule—kidney cancer	0.000857	0.0368	CbGeAlD
Risperidone—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000841	0.0362	CbGeAlD
Risperidone—ADRA1B—renal system—kidney cancer	0.000825	0.0355	CbGeAlD
Risperidone—ADRA1B—kidney—kidney cancer	0.000798	0.0343	CbGeAlD
Risperidone—H1F0—renal system—kidney cancer	0.000779	0.0335	CbGeAlD
Risperidone—H1F0—kidney—kidney cancer	0.000753	0.0324	CbGeAlD
Risperidone—H1F0—cortex of kidney—kidney cancer	0.000733	0.0315	CbGeAlD
Risperidone—H1F0—gonad—kidney cancer	0.000699	0.03	CbGeAlD
Risperidone—H1F0—cardiac atrium—kidney cancer	0.000698	0.03	CbGeAlD
Risperidone—HTR1D—kidney—kidney cancer	0.000583	0.0251	CbGeAlD
Risperidone—HTR2B—cortex of kidney—kidney cancer	0.000529	0.0227	CbGeAlD
Risperidone—HTR1A—renal system—kidney cancer	0.000503	0.0216	CbGeAlD
Risperidone—ADRA2C—nephron tubule—kidney cancer	0.000486	0.0209	CbGeAlD
Risperidone—HTR7—renal system—kidney cancer	0.000481	0.0207	CbGeAlD
Risperidone—HTR7—kidney—kidney cancer	0.000465	0.02	CbGeAlD
Risperidone—ADRA1A—renal system—kidney cancer	0.000464	0.0199	CbGeAlD
Risperidone—KCNH2—renal system—kidney cancer	0.000448	0.0193	CbGeAlD
Risperidone—ADRA2C—renal system—kidney cancer	0.000442	0.019	CbGeAlD
Risperidone—HTR7—gonad—kidney cancer	0.000431	0.0185	CbGeAlD
Risperidone—ADRA2C—kidney—kidney cancer	0.000427	0.0184	CbGeAlD
Risperidone—ADRA2C—cortex of kidney—kidney cancer	0.000416	0.0179	CbGeAlD
Risperidone—CYP3A5—nephron tubule—kidney cancer	0.000407	0.0175	CbGeAlD
Risperidone—KCNH2—cardiac atrium—kidney cancer	0.000401	0.0172	CbGeAlD
Risperidone—ADRA2C—cardiac atrium—kidney cancer	0.000396	0.017	CbGeAlD
Risperidone—CYP3A5—renal system—kidney cancer	0.00037	0.0159	CbGeAlD
Risperidone—CYP3A5—kidney—kidney cancer	0.000358	0.0154	CbGeAlD
Risperidone—CYP3A5—cortex of kidney—kidney cancer	0.000348	0.015	CbGeAlD
Risperidone—ADRA2A—cortex of kidney—kidney cancer	0.000332	0.0143	CbGeAlD
Risperidone—ADRA2A—gonad—kidney cancer	0.000316	0.0136	CbGeAlD
Risperidone—ADRA2A—cardiac atrium—kidney cancer	0.000316	0.0136	CbGeAlD
Risperidone—HTR2A—renal system—kidney cancer	0.0003	0.0129	CbGeAlD
Risperidone—HTR2A—kidney—kidney cancer	0.00029	0.0125	CbGeAlD
Risperidone—CYP3A4—renal system—kidney cancer	0.000278	0.0119	CbGeAlD
Risperidone—CYP2D6—renal system—kidney cancer	0.000273	0.0117	CbGeAlD
Risperidone—HTR2A—gonad—kidney cancer	0.000269	0.0116	CbGeAlD
Risperidone—CYP3A4—kidney—kidney cancer	0.000268	0.0115	CbGeAlD
Risperidone—CYP2D6—kidney—kidney cancer	0.000264	0.0113	CbGeAlD
Risperidone—ABCB1—nephron tubule—kidney cancer	0.000216	0.00929	CbGeAlD
Risperidone—ABCB1—renal system—kidney cancer	0.000196	0.00844	CbGeAlD
Risperidone—ABCB1—kidney—kidney cancer	0.00019	0.00816	CbGeAlD
Risperidone—ABCB1—cortex of kidney—kidney cancer	0.000185	0.00795	CbGeAlD
Risperidone—ABCB1—gonad—kidney cancer	0.000176	0.00757	CbGeAlD
Risperidone—Nervous system disorder—Paclitaxel—kidney cancer	4.39e-05	0.000168	CcSEcCtD
Risperidone—Hypokalaemia—Doxorubicin—kidney cancer	4.38e-05	0.000168	CcSEcCtD
Risperidone—Thrombocytopenia—Paclitaxel—kidney cancer	4.38e-05	0.000167	CcSEcCtD
Risperidone—Tachycardia—Paclitaxel—kidney cancer	4.37e-05	0.000167	CcSEcCtD
Risperidone—Rash—Sorafenib—kidney cancer	4.36e-05	0.000167	CcSEcCtD
Risperidone—Dermatitis—Sorafenib—kidney cancer	4.36e-05	0.000167	CcSEcCtD
Risperidone—Back pain—Capecitabine—kidney cancer	4.35e-05	0.000166	CcSEcCtD
Risperidone—Breast disorder—Doxorubicin—kidney cancer	4.35e-05	0.000166	CcSEcCtD
Risperidone—Skin disorder—Paclitaxel—kidney cancer	4.35e-05	0.000166	CcSEcCtD
Risperidone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.34e-05	0.000166	CcSEcCtD
Risperidone—Headache—Sorafenib—kidney cancer	4.34e-05	0.000166	CcSEcCtD
Risperidone—Muscle spasms—Capecitabine—kidney cancer	4.33e-05	0.000165	CcSEcCtD
Risperidone—Hyperhidrosis—Paclitaxel—kidney cancer	4.33e-05	0.000165	CcSEcCtD
Risperidone—Diarrhoea—Dactinomycin—kidney cancer	4.31e-05	0.000165	CcSEcCtD
Risperidone—Nasopharyngitis—Doxorubicin—kidney cancer	4.31e-05	0.000165	CcSEcCtD
Risperidone—Anorexia—Paclitaxel—kidney cancer	4.27e-05	0.000163	CcSEcCtD
Risperidone—Gastritis—Doxorubicin—kidney cancer	4.26e-05	0.000163	CcSEcCtD
Risperidone—Muscular weakness—Doxorubicin—kidney cancer	4.25e-05	0.000162	CcSEcCtD
Risperidone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.25e-05	0.000162	CcSEcCtD
Risperidone—Vision blurred—Capecitabine—kidney cancer	4.24e-05	0.000162	CcSEcCtD
Risperidone—Vomiting—Sunitinib—kidney cancer	4.24e-05	0.000162	CcSEcCtD
Risperidone—Body temperature increased—Gemcitabine—kidney cancer	4.23e-05	0.000162	CcSEcCtD
Risperidone—Tremor—Capecitabine—kidney cancer	4.22e-05	0.000161	CcSEcCtD
Risperidone—Rash—Sunitinib—kidney cancer	4.2e-05	0.000161	CcSEcCtD
Risperidone—Dermatitis—Sunitinib—kidney cancer	4.2e-05	0.00016	CcSEcCtD
Risperidone—Abdominal distension—Doxorubicin—kidney cancer	4.19e-05	0.00016	CcSEcCtD
Risperidone—Hypotension—Paclitaxel—kidney cancer	4.18e-05	0.00016	CcSEcCtD
Risperidone—Ill-defined disorder—Capecitabine—kidney cancer	4.17e-05	0.00016	CcSEcCtD
Risperidone—Headache—Sunitinib—kidney cancer	4.17e-05	0.00016	CcSEcCtD
Risperidone—Dysphagia—Doxorubicin—kidney cancer	4.16e-05	0.000159	CcSEcCtD
Risperidone—Influenza—Doxorubicin—kidney cancer	4.16e-05	0.000159	CcSEcCtD
Risperidone—Asthma—Doxorubicin—kidney cancer	4.16e-05	0.000159	CcSEcCtD
Risperidone—Anaemia—Capecitabine—kidney cancer	4.16e-05	0.000159	CcSEcCtD
Risperidone—Hypersensitivity—Vincristine—kidney cancer	4.15e-05	0.000159	CcSEcCtD
Risperidone—Nausea—Sorafenib—kidney cancer	4.11e-05	0.000157	CcSEcCtD
Risperidone—Pancreatitis—Doxorubicin—kidney cancer	4.08e-05	0.000156	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.08e-05	0.000156	CcSEcCtD
Risperidone—Malaise—Capecitabine—kidney cancer	4.06e-05	0.000155	CcSEcCtD
Risperidone—Angina pectoris—Doxorubicin—kidney cancer	4.05e-05	0.000155	CcSEcCtD
Risperidone—Insomnia—Paclitaxel—kidney cancer	4.05e-05	0.000155	CcSEcCtD
Risperidone—Vertigo—Capecitabine—kidney cancer	4.04e-05	0.000155	CcSEcCtD
Risperidone—Asthenia—Vincristine—kidney cancer	4.04e-05	0.000155	CcSEcCtD
Risperidone—Syncope—Capecitabine—kidney cancer	4.04e-05	0.000154	CcSEcCtD
Risperidone—Leukopenia—Capecitabine—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Risperidone—Paraesthesia—Paclitaxel—kidney cancer	4.02e-05	0.000154	CcSEcCtD
Risperidone—Vomiting—Dactinomycin—kidney cancer	4.01e-05	0.000153	CcSEcCtD
Risperidone—Bronchitis—Doxorubicin—kidney cancer	4e-05	0.000153	CcSEcCtD
Risperidone—Dyspnoea—Paclitaxel—kidney cancer	3.99e-05	0.000153	CcSEcCtD
Risperidone—Somnolence—Paclitaxel—kidney cancer	3.98e-05	0.000152	CcSEcCtD
Risperidone—Palpitations—Capecitabine—kidney cancer	3.98e-05	0.000152	CcSEcCtD
Risperidone—Rash—Dactinomycin—kidney cancer	3.98e-05	0.000152	CcSEcCtD
Risperidone—Nausea—Sunitinib—kidney cancer	3.96e-05	0.000151	CcSEcCtD
Risperidone—Loss of consciousness—Capecitabine—kidney cancer	3.95e-05	0.000151	CcSEcCtD
Risperidone—Dyspepsia—Paclitaxel—kidney cancer	3.94e-05	0.000151	CcSEcCtD
Risperidone—Cough—Capecitabine—kidney cancer	3.93e-05	0.00015	CcSEcCtD
Risperidone—Dysuria—Doxorubicin—kidney cancer	3.89e-05	0.000149	CcSEcCtD
Risperidone—Neutropenia—Doxorubicin—kidney cancer	3.89e-05	0.000149	CcSEcCtD
Risperidone—Decreased appetite—Paclitaxel—kidney cancer	3.89e-05	0.000149	CcSEcCtD
Risperidone—Hypertension—Capecitabine—kidney cancer	3.88e-05	0.000149	CcSEcCtD
Risperidone—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.87e-05	0.000148	CcSEcCtD
Risperidone—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.86e-05	0.000148	CcSEcCtD
Risperidone—Fatigue—Paclitaxel—kidney cancer	3.86e-05	0.000147	CcSEcCtD
Risperidone—Diarrhoea—Vincristine—kidney cancer	3.85e-05	0.000147	CcSEcCtD
Risperidone—Pollakiuria—Doxorubicin—kidney cancer	3.85e-05	0.000147	CcSEcCtD
Risperidone—Asthenia—Gemcitabine—kidney cancer	3.83e-05	0.000147	CcSEcCtD
Risperidone—Arthralgia—Capecitabine—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Risperidone—Chest pain—Capecitabine—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Risperidone—Myalgia—Capecitabine—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Risperidone—Pain—Paclitaxel—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Risperidone—Constipation—Paclitaxel—kidney cancer	3.83e-05	0.000146	CcSEcCtD
Risperidone—Anxiety—Capecitabine—kidney cancer	3.82e-05	0.000146	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.8e-05	0.000145	CcSEcCtD
Risperidone—Photosensitivity reaction—Doxorubicin—kidney cancer	3.8e-05	0.000145	CcSEcCtD
Risperidone—Weight increased—Doxorubicin—kidney cancer	3.79e-05	0.000145	CcSEcCtD
Risperidone—Discomfort—Capecitabine—kidney cancer	3.78e-05	0.000145	CcSEcCtD
Risperidone—Pruritus—Gemcitabine—kidney cancer	3.78e-05	0.000145	CcSEcCtD
Risperidone—Weight decreased—Doxorubicin—kidney cancer	3.77e-05	0.000144	CcSEcCtD
Risperidone—Hyperglycaemia—Doxorubicin—kidney cancer	3.75e-05	0.000144	CcSEcCtD
Risperidone—Dry mouth—Capecitabine—kidney cancer	3.75e-05	0.000143	CcSEcCtD
Risperidone—Nausea—Dactinomycin—kidney cancer	3.75e-05	0.000143	CcSEcCtD
Risperidone—Pneumonia—Doxorubicin—kidney cancer	3.73e-05	0.000143	CcSEcCtD
Risperidone—Dizziness—Vincristine—kidney cancer	3.73e-05	0.000142	CcSEcCtD
Risperidone—Infestation NOS—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Risperidone—Infestation—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Risperidone—Drowsiness—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Risperidone—Confusional state—Capecitabine—kidney cancer	3.7e-05	0.000142	CcSEcCtD
Risperidone—Feeling abnormal—Paclitaxel—kidney cancer	3.69e-05	0.000141	CcSEcCtD
Risperidone—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.68e-05	0.000141	CcSEcCtD
Risperidone—Oedema—Capecitabine—kidney cancer	3.67e-05	0.00014	CcSEcCtD
Risperidone—Gastrointestinal pain—Paclitaxel—kidney cancer	3.66e-05	0.00014	CcSEcCtD
Risperidone—Diarrhoea—Gemcitabine—kidney cancer	3.66e-05	0.00014	CcSEcCtD
Risperidone—Renal failure—Doxorubicin—kidney cancer	3.65e-05	0.000139	CcSEcCtD
Risperidone—Infection—Capecitabine—kidney cancer	3.65e-05	0.000139	CcSEcCtD
Risperidone—Neuropathy peripheral—Doxorubicin—kidney cancer	3.64e-05	0.000139	CcSEcCtD
Risperidone—Jaundice—Doxorubicin—kidney cancer	3.62e-05	0.000138	CcSEcCtD
Risperidone—Stomatitis—Doxorubicin—kidney cancer	3.62e-05	0.000138	CcSEcCtD
Risperidone—Shock—Capecitabine—kidney cancer	3.61e-05	0.000138	CcSEcCtD
Risperidone—Urinary tract infection—Doxorubicin—kidney cancer	3.61e-05	0.000138	CcSEcCtD
Risperidone—Conjunctivitis—Doxorubicin—kidney cancer	3.61e-05	0.000138	CcSEcCtD
Risperidone—Nervous system disorder—Capecitabine—kidney cancer	3.6e-05	0.000138	CcSEcCtD
Risperidone—Thrombocytopenia—Capecitabine—kidney cancer	3.6e-05	0.000137	CcSEcCtD
Risperidone—Tachycardia—Capecitabine—kidney cancer	3.58e-05	0.000137	CcSEcCtD
Risperidone—Vomiting—Vincristine—kidney cancer	3.58e-05	0.000137	CcSEcCtD
Risperidone—Skin disorder—Capecitabine—kidney cancer	3.57e-05	0.000136	CcSEcCtD
Risperidone—Sweating—Doxorubicin—kidney cancer	3.56e-05	0.000136	CcSEcCtD
Risperidone—Urticaria—Paclitaxel—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Risperidone—Rash—Vincristine—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Risperidone—Hyperhidrosis—Capecitabine—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Risperidone—Dermatitis—Vincristine—kidney cancer	3.55e-05	0.000136	CcSEcCtD
Risperidone—Haematuria—Doxorubicin—kidney cancer	3.54e-05	0.000135	CcSEcCtD
Risperidone—Abdominal pain—Paclitaxel—kidney cancer	3.54e-05	0.000135	CcSEcCtD
Risperidone—Body temperature increased—Paclitaxel—kidney cancer	3.54e-05	0.000135	CcSEcCtD
Risperidone—Headache—Vincristine—kidney cancer	3.53e-05	0.000135	CcSEcCtD
Risperidone—Hepatobiliary disease—Doxorubicin—kidney cancer	3.51e-05	0.000134	CcSEcCtD
Risperidone—Epistaxis—Doxorubicin—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Risperidone—Anorexia—Capecitabine—kidney cancer	3.5e-05	0.000134	CcSEcCtD
Risperidone—Sinusitis—Doxorubicin—kidney cancer	3.48e-05	0.000133	CcSEcCtD
Risperidone—Agranulocytosis—Doxorubicin—kidney cancer	3.46e-05	0.000132	CcSEcCtD
Risperidone—Hypotension—Capecitabine—kidney cancer	3.43e-05	0.000131	CcSEcCtD
Risperidone—Vomiting—Gemcitabine—kidney cancer	3.4e-05	0.00013	CcSEcCtD
Risperidone—Bradycardia—Doxorubicin—kidney cancer	3.39e-05	0.00013	CcSEcCtD
Risperidone—Rash—Gemcitabine—kidney cancer	3.37e-05	0.000129	CcSEcCtD
Risperidone—Dermatitis—Gemcitabine—kidney cancer	3.37e-05	0.000129	CcSEcCtD
Risperidone—Haemoglobin—Doxorubicin—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Risperidone—Headache—Gemcitabine—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Risperidone—Nausea—Vincristine—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.35e-05	0.000128	CcSEcCtD
Risperidone—Rhinitis—Doxorubicin—kidney cancer	3.34e-05	0.000128	CcSEcCtD
Risperidone—Haemorrhage—Doxorubicin—kidney cancer	3.33e-05	0.000127	CcSEcCtD
Risperidone—Hepatitis—Doxorubicin—kidney cancer	3.33e-05	0.000127	CcSEcCtD
Risperidone—Insomnia—Capecitabine—kidney cancer	3.32e-05	0.000127	CcSEcCtD
Risperidone—Hypoaesthesia—Doxorubicin—kidney cancer	3.32e-05	0.000127	CcSEcCtD
Risperidone—Pharyngitis—Doxorubicin—kidney cancer	3.31e-05	0.000126	CcSEcCtD
Risperidone—Paraesthesia—Capecitabine—kidney cancer	3.3e-05	0.000126	CcSEcCtD
Risperidone—Hypersensitivity—Paclitaxel—kidney cancer	3.3e-05	0.000126	CcSEcCtD
Risperidone—Urinary tract disorder—Doxorubicin—kidney cancer	3.29e-05	0.000126	CcSEcCtD
Risperidone—Oedema peripheral—Doxorubicin—kidney cancer	3.28e-05	0.000125	CcSEcCtD
Risperidone—Connective tissue disorder—Doxorubicin—kidney cancer	3.27e-05	0.000125	CcSEcCtD
Risperidone—Dyspnoea—Capecitabine—kidney cancer	3.27e-05	0.000125	CcSEcCtD
Risperidone—Urethral disorder—Doxorubicin—kidney cancer	3.27e-05	0.000125	CcSEcCtD
Risperidone—Dyspepsia—Capecitabine—kidney cancer	3.23e-05	0.000124	CcSEcCtD
Risperidone—Visual impairment—Doxorubicin—kidney cancer	3.21e-05	0.000123	CcSEcCtD
Risperidone—Asthenia—Paclitaxel—kidney cancer	3.21e-05	0.000123	CcSEcCtD
Risperidone—Decreased appetite—Capecitabine—kidney cancer	3.19e-05	0.000122	CcSEcCtD
Risperidone—Nausea—Gemcitabine—kidney cancer	3.17e-05	0.000121	CcSEcCtD
Risperidone—Gastrointestinal disorder—Capecitabine—kidney cancer	3.17e-05	0.000121	CcSEcCtD
Risperidone—Fatigue—Capecitabine—kidney cancer	3.17e-05	0.000121	CcSEcCtD
Risperidone—Pruritus—Paclitaxel—kidney cancer	3.17e-05	0.000121	CcSEcCtD
Risperidone—Erythema multiforme—Doxorubicin—kidney cancer	3.15e-05	0.00012	CcSEcCtD
Risperidone—Pain—Capecitabine—kidney cancer	3.14e-05	0.00012	CcSEcCtD
Risperidone—Constipation—Capecitabine—kidney cancer	3.14e-05	0.00012	CcSEcCtD
Risperidone—Eye disorder—Doxorubicin—kidney cancer	3.11e-05	0.000119	CcSEcCtD
Risperidone—Tinnitus—Doxorubicin—kidney cancer	3.11e-05	0.000119	CcSEcCtD
Risperidone—Cardiac disorder—Doxorubicin—kidney cancer	3.09e-05	0.000118	CcSEcCtD
Risperidone—Flushing—Doxorubicin—kidney cancer	3.09e-05	0.000118	CcSEcCtD
Risperidone—Diarrhoea—Paclitaxel—kidney cancer	3.06e-05	0.000117	CcSEcCtD
Risperidone—Feeling abnormal—Capecitabine—kidney cancer	3.03e-05	0.000116	CcSEcCtD
Risperidone—Angiopathy—Doxorubicin—kidney cancer	3.02e-05	0.000116	CcSEcCtD
Risperidone—Immune system disorder—Doxorubicin—kidney cancer	3.01e-05	0.000115	CcSEcCtD
Risperidone—Gastrointestinal pain—Capecitabine—kidney cancer	3e-05	0.000115	CcSEcCtD
Risperidone—Mediastinal disorder—Doxorubicin—kidney cancer	3e-05	0.000115	CcSEcCtD
Risperidone—Chills—Doxorubicin—kidney cancer	2.99e-05	0.000114	CcSEcCtD
Risperidone—Arrhythmia—Doxorubicin—kidney cancer	2.98e-05	0.000114	CcSEcCtD
Risperidone—Dizziness—Paclitaxel—kidney cancer	2.96e-05	0.000113	CcSEcCtD
Risperidone—Alopecia—Doxorubicin—kidney cancer	2.94e-05	0.000113	CcSEcCtD
Risperidone—Mental disorder—Doxorubicin—kidney cancer	2.92e-05	0.000112	CcSEcCtD
Risperidone—Urticaria—Capecitabine—kidney cancer	2.92e-05	0.000112	CcSEcCtD
Risperidone—Abdominal pain—Capecitabine—kidney cancer	2.9e-05	0.000111	CcSEcCtD
Risperidone—Body temperature increased—Capecitabine—kidney cancer	2.9e-05	0.000111	CcSEcCtD
Risperidone—Erythema—Doxorubicin—kidney cancer	2.9e-05	0.000111	CcSEcCtD
Risperidone—Malnutrition—Doxorubicin—kidney cancer	2.9e-05	0.000111	CcSEcCtD
Risperidone—Flatulence—Doxorubicin—kidney cancer	2.86e-05	0.000109	CcSEcCtD
Risperidone—Tension—Doxorubicin—kidney cancer	2.85e-05	0.000109	CcSEcCtD
Risperidone—Vomiting—Paclitaxel—kidney cancer	2.85e-05	0.000109	CcSEcCtD
Risperidone—Dysgeusia—Doxorubicin—kidney cancer	2.84e-05	0.000109	CcSEcCtD
Risperidone—Rash—Paclitaxel—kidney cancer	2.82e-05	0.000108	CcSEcCtD
Risperidone—Dermatitis—Paclitaxel—kidney cancer	2.82e-05	0.000108	CcSEcCtD
Risperidone—Nervousness—Doxorubicin—kidney cancer	2.82e-05	0.000108	CcSEcCtD
Risperidone—Back pain—Doxorubicin—kidney cancer	2.81e-05	0.000107	CcSEcCtD
Risperidone—Headache—Paclitaxel—kidney cancer	2.8e-05	0.000107	CcSEcCtD
Risperidone—Muscle spasms—Doxorubicin—kidney cancer	2.79e-05	0.000107	CcSEcCtD
Risperidone—Vision blurred—Doxorubicin—kidney cancer	2.73e-05	0.000104	CcSEcCtD
Risperidone—Hypersensitivity—Capecitabine—kidney cancer	2.71e-05	0.000103	CcSEcCtD
Risperidone—Ill-defined disorder—Doxorubicin—kidney cancer	2.69e-05	0.000103	CcSEcCtD
Risperidone—Anaemia—Doxorubicin—kidney cancer	2.68e-05	0.000102	CcSEcCtD
Risperidone—Agitation—Doxorubicin—kidney cancer	2.67e-05	0.000102	CcSEcCtD
Risperidone—Nausea—Paclitaxel—kidney cancer	2.66e-05	0.000102	CcSEcCtD
Risperidone—Asthenia—Capecitabine—kidney cancer	2.63e-05	0.000101	CcSEcCtD
Risperidone—Malaise—Doxorubicin—kidney cancer	2.62e-05	0.0001	CcSEcCtD
Risperidone—Vertigo—Doxorubicin—kidney cancer	2.61e-05	9.96e-05	CcSEcCtD
Risperidone—Syncope—Doxorubicin—kidney cancer	2.6e-05	9.94e-05	CcSEcCtD
Risperidone—Pruritus—Capecitabine—kidney cancer	2.6e-05	9.93e-05	CcSEcCtD
Risperidone—Leukopenia—Doxorubicin—kidney cancer	2.6e-05	9.92e-05	CcSEcCtD
Risperidone—Palpitations—Doxorubicin—kidney cancer	2.56e-05	9.8e-05	CcSEcCtD
Risperidone—Loss of consciousness—Doxorubicin—kidney cancer	2.55e-05	9.74e-05	CcSEcCtD
Risperidone—Cough—Doxorubicin—kidney cancer	2.53e-05	9.67e-05	CcSEcCtD
Risperidone—Convulsion—Doxorubicin—kidney cancer	2.51e-05	9.61e-05	CcSEcCtD
Risperidone—Diarrhoea—Capecitabine—kidney cancer	2.51e-05	9.6e-05	CcSEcCtD
Risperidone—Hypertension—Doxorubicin—kidney cancer	2.5e-05	9.57e-05	CcSEcCtD
Risperidone—Myalgia—Doxorubicin—kidney cancer	2.47e-05	9.44e-05	CcSEcCtD
Risperidone—Chest pain—Doxorubicin—kidney cancer	2.47e-05	9.44e-05	CcSEcCtD
Risperidone—Arthralgia—Doxorubicin—kidney cancer	2.47e-05	9.44e-05	CcSEcCtD
Risperidone—Anxiety—Doxorubicin—kidney cancer	2.46e-05	9.41e-05	CcSEcCtD
Risperidone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.45e-05	9.37e-05	CcSEcCtD
Risperidone—Discomfort—Doxorubicin—kidney cancer	2.44e-05	9.33e-05	CcSEcCtD
Risperidone—Dizziness—Capecitabine—kidney cancer	2.43e-05	9.28e-05	CcSEcCtD
Risperidone—Dry mouth—Doxorubicin—kidney cancer	2.41e-05	9.23e-05	CcSEcCtD
Risperidone—Confusional state—Doxorubicin—kidney cancer	2.39e-05	9.12e-05	CcSEcCtD
Risperidone—Anaphylactic shock—Doxorubicin—kidney cancer	2.37e-05	9.05e-05	CcSEcCtD
Risperidone—Oedema—Doxorubicin—kidney cancer	2.37e-05	9.05e-05	CcSEcCtD
Risperidone—Infection—Doxorubicin—kidney cancer	2.35e-05	8.99e-05	CcSEcCtD
Risperidone—Vomiting—Capecitabine—kidney cancer	2.33e-05	8.93e-05	CcSEcCtD
Risperidone—Shock—Doxorubicin—kidney cancer	2.33e-05	8.9e-05	CcSEcCtD
Risperidone—Nervous system disorder—Doxorubicin—kidney cancer	2.32e-05	8.87e-05	CcSEcCtD
Risperidone—Thrombocytopenia—Doxorubicin—kidney cancer	2.32e-05	8.86e-05	CcSEcCtD
Risperidone—Rash—Capecitabine—kidney cancer	2.32e-05	8.85e-05	CcSEcCtD
Risperidone—Dermatitis—Capecitabine—kidney cancer	2.31e-05	8.84e-05	CcSEcCtD
Risperidone—Tachycardia—Doxorubicin—kidney cancer	2.31e-05	8.83e-05	CcSEcCtD
Risperidone—Headache—Capecitabine—kidney cancer	2.3e-05	8.79e-05	CcSEcCtD
Risperidone—Skin disorder—Doxorubicin—kidney cancer	2.3e-05	8.79e-05	CcSEcCtD
Risperidone—Hyperhidrosis—Doxorubicin—kidney cancer	2.29e-05	8.75e-05	CcSEcCtD
Risperidone—Anorexia—Doxorubicin—kidney cancer	2.26e-05	8.63e-05	CcSEcCtD
Risperidone—Hypotension—Doxorubicin—kidney cancer	2.21e-05	8.46e-05	CcSEcCtD
Risperidone—Nausea—Capecitabine—kidney cancer	2.18e-05	8.34e-05	CcSEcCtD
Risperidone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.16e-05	8.24e-05	CcSEcCtD
Risperidone—Insomnia—Doxorubicin—kidney cancer	2.14e-05	8.18e-05	CcSEcCtD
Risperidone—Paraesthesia—Doxorubicin—kidney cancer	2.13e-05	8.13e-05	CcSEcCtD
Risperidone—Dyspnoea—Doxorubicin—kidney cancer	2.11e-05	8.07e-05	CcSEcCtD
Risperidone—Somnolence—Doxorubicin—kidney cancer	2.1e-05	8.04e-05	CcSEcCtD
Risperidone—Dyspepsia—Doxorubicin—kidney cancer	2.08e-05	7.97e-05	CcSEcCtD
Risperidone—Decreased appetite—Doxorubicin—kidney cancer	2.06e-05	7.87e-05	CcSEcCtD
Risperidone—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.04e-05	7.81e-05	CcSEcCtD
Risperidone—Fatigue—Doxorubicin—kidney cancer	2.04e-05	7.8e-05	CcSEcCtD
Risperidone—Constipation—Doxorubicin—kidney cancer	2.02e-05	7.74e-05	CcSEcCtD
Risperidone—Pain—Doxorubicin—kidney cancer	2.02e-05	7.74e-05	CcSEcCtD
Risperidone—Feeling abnormal—Doxorubicin—kidney cancer	1.95e-05	7.46e-05	CcSEcCtD
Risperidone—Gastrointestinal pain—Doxorubicin—kidney cancer	1.94e-05	7.4e-05	CcSEcCtD
Risperidone—Urticaria—Doxorubicin—kidney cancer	1.88e-05	7.19e-05	CcSEcCtD
Risperidone—Abdominal pain—Doxorubicin—kidney cancer	1.87e-05	7.15e-05	CcSEcCtD
Risperidone—Body temperature increased—Doxorubicin—kidney cancer	1.87e-05	7.15e-05	CcSEcCtD
Risperidone—Hypersensitivity—Doxorubicin—kidney cancer	1.74e-05	6.67e-05	CcSEcCtD
Risperidone—Asthenia—Doxorubicin—kidney cancer	1.7e-05	6.49e-05	CcSEcCtD
Risperidone—Pruritus—Doxorubicin—kidney cancer	1.67e-05	6.4e-05	CcSEcCtD
Risperidone—Diarrhoea—Doxorubicin—kidney cancer	1.62e-05	6.19e-05	CcSEcCtD
Risperidone—Dizziness—Doxorubicin—kidney cancer	1.57e-05	5.98e-05	CcSEcCtD
Risperidone—Vomiting—Doxorubicin—kidney cancer	1.51e-05	5.75e-05	CcSEcCtD
Risperidone—Rash—Doxorubicin—kidney cancer	1.49e-05	5.71e-05	CcSEcCtD
Risperidone—Dermatitis—Doxorubicin—kidney cancer	1.49e-05	5.7e-05	CcSEcCtD
Risperidone—Headache—Doxorubicin—kidney cancer	1.48e-05	5.67e-05	CcSEcCtD
Risperidone—Nausea—Doxorubicin—kidney cancer	1.41e-05	5.37e-05	CcSEcCtD
Risperidone—HTR2C—Signaling Pathways—MTOR—kidney cancer	3.11e-06	7.47e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PTEN—kidney cancer	3.1e-06	7.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RAF1—kidney cancer	3.09e-06	7.44e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK3—kidney cancer	3.09e-06	7.43e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—RELA—kidney cancer	3.08e-06	7.41e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—KRAS—kidney cancer	3.08e-06	7.41e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	3.07e-06	7.38e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	3.07e-06	7.38e-05	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	3.06e-06	7.37e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—ERBB2—kidney cancer	3.06e-06	7.36e-05	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—PIK3CA—kidney cancer	3.06e-06	7.36e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—POMC—kidney cancer	3.05e-06	7.33e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RAF1—kidney cancer	3.04e-06	7.33e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CDKN1B—kidney cancer	3.03e-06	7.3e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—RELA—kidney cancer	3.03e-06	7.29e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—KRAS—kidney cancer	3.03e-06	7.29e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK3—kidney cancer	3.03e-06	7.28e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MYC—kidney cancer	3.02e-06	7.28e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—KRAS—kidney cancer	3.02e-06	7.27e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MTOR—kidney cancer	3.02e-06	7.27e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	3.01e-06	7.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—BRAF—kidney cancer	3.01e-06	7.24e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MYC—kidney cancer	3.01e-06	7.23e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—BCHE—kidney cancer	3e-06	7.23e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—VEGFA—kidney cancer	3e-06	7.23e-05	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	3e-06	7.22e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK3—kidney cancer	2.98e-06	7.16e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MTOR—kidney cancer	2.97e-06	7.15e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—IL2—kidney cancer	2.97e-06	7.15e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.97e-06	7.14e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	2.97e-06	7.14e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—MAPK1—kidney cancer	2.96e-06	7.12e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MYC—kidney cancer	2.94e-06	7.08e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—MAPK1—kidney cancer	2.94e-06	7.07e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CDKN1B—kidney cancer	2.93e-06	7.05e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	2.92e-06	7.02e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CDKN1B—kidney cancer	2.91e-06	7.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTGS2—kidney cancer	2.91e-06	7e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MYC—kidney cancer	2.9e-06	6.97e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CCND1—kidney cancer	2.9e-06	6.97e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—JUN—kidney cancer	2.89e-06	6.95e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—MAPK1—kidney cancer	2.88e-06	6.93e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—CTNNB1—kidney cancer	2.87e-06	6.9e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—IL2—kidney cancer	2.87e-06	6.9e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.87e-06	6.9e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—IL2—kidney cancer	2.85e-06	6.86e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK3—kidney cancer	2.84e-06	6.84e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CDKN1B—kidney cancer	2.83e-06	6.82e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—VEGFA—kidney cancer	2.83e-06	6.82e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—MAPK1—kidney cancer	2.83e-06	6.82e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	2.83e-06	6.81e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RAF1—kidney cancer	2.81e-06	6.75e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—VEGFA—kidney cancer	2.8e-06	6.73e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—KRAS—kidney cancer	2.8e-06	6.73e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—RELA—kidney cancer	2.79e-06	6.72e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CCND1—kidney cancer	2.79e-06	6.72e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PTEN—kidney cancer	2.79e-06	6.72e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	2.79e-06	6.71e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—JUN—kidney cancer	2.79e-06	6.71e-05	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.79e-06	6.71e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	2.78e-06	6.7e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CCND1—kidney cancer	2.78e-06	6.69e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—ERBB2—kidney cancer	2.78e-06	6.68e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	2.78e-06	6.68e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—KRAS—kidney cancer	2.78e-06	6.68e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—JUN—kidney cancer	2.77e-06	6.68e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—IL2—kidney cancer	2.77e-06	6.67e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	2.77e-06	6.66e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MYC—kidney cancer	2.76e-06	6.65e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RAF1—kidney cancer	2.76e-06	6.65e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RAF1—kidney cancer	2.76e-06	6.63e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.76e-06	6.63e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	2.75e-06	6.62e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—RELA—kidney cancer	2.75e-06	6.62e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—RELA—kidney cancer	2.74e-06	6.6e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MTOR—kidney cancer	2.74e-06	6.59e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—ERBB2—kidney cancer	2.73e-06	6.58e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.73e-06	6.57e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—ERBB2—kidney cancer	2.73e-06	6.56e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.72e-06	6.56e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—KRAS—kidney cancer	2.72e-06	6.54e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.7e-06	6.51e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CCND1—kidney cancer	2.7e-06	6.51e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—MAPK1—kidney cancer	2.7e-06	6.51e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—JUN—kidney cancer	2.7e-06	6.49e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PTEN—kidney cancer	2.7e-06	6.49e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MTOR—kidney cancer	2.7e-06	6.49e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.69e-06	6.48e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MTOR—kidney cancer	2.69e-06	6.47e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PTEN—kidney cancer	2.68e-06	6.46e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK3—kidney cancer	2.68e-06	6.45e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	2.68e-06	6.44e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2.68e-06	6.44e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—KRAS—kidney cancer	2.68e-06	6.44e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTGS2—kidney cancer	2.66e-06	6.41e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CCND1—kidney cancer	2.66e-06	6.4e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—JUN—kidney cancer	2.66e-06	6.39e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK3—kidney cancer	2.64e-06	6.36e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MTOR—kidney cancer	2.64e-06	6.35e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	2.64e-06	6.34e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PTEN—kidney cancer	2.61e-06	6.28e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MYC—kidney cancer	2.61e-06	6.27e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MYC—kidney cancer	2.57e-06	6.19e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CDKN1B—kidney cancer	2.57e-06	6.19e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PTEN—kidney cancer	2.57e-06	6.18e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—PIK3CA—kidney cancer	2.57e-06	6.18e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—KRAS—kidney cancer	2.55e-06	6.15e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—PIK3CA—kidney cancer	2.55e-06	6.14e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—MAPK1—kidney cancer	2.55e-06	6.14e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PTEN—kidney cancer	2.54e-06	6.1e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	2.53e-06	6.09e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	2.53e-06	6.09e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CDKN1B—kidney cancer	2.53e-06	6.08e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	2.52e-06	6.07e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—POMC—kidney cancer	2.52e-06	6.06e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—IL2—kidney cancer	2.52e-06	6.06e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—MAPK1—kidney cancer	2.52e-06	6.05e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RAF1—kidney cancer	2.51e-06	6.05e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—RELA—kidney cancer	2.5e-06	6.02e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—PIK3CA—kidney cancer	2.5e-06	6.01e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.49e-06	5.98e-05	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—TP53—kidney cancer	2.48e-06	5.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.48e-06	5.96e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—IL2—kidney cancer	2.48e-06	5.96e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—IL2—kidney cancer	2.47e-06	5.95e-05	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—TP53—kidney cancer	2.47e-06	5.94e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—PIK3CA—kidney cancer	2.46e-06	5.91e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CCND1—kidney cancer	2.45e-06	5.9e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.45e-06	5.9e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—JUN—kidney cancer	2.45e-06	5.89e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.44e-06	5.86e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.43e-06	5.85e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.43e-06	5.84e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.42e-06	5.83e-05	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—TP53—kidney cancer	2.42e-06	5.81e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.41e-06	5.81e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—JUN—kidney cancer	2.41e-06	5.8e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CCND1—kidney cancer	2.41e-06	5.8e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—KRAS—kidney cancer	2.41e-06	5.8e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—JUN—kidney cancer	2.4e-06	5.78e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.39e-06	5.75e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTP1—kidney cancer	2.39e-06	5.75e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	2.39e-06	5.74e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.39e-06	5.74e-05	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—TP53—kidney cancer	2.38e-06	5.72e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—KRAS—kidney cancer	2.38e-06	5.72e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—POMC—kidney cancer	2.38e-06	5.71e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PTEN—kidney cancer	2.37e-06	5.7e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.36e-06	5.69e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.36e-06	5.68e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	2.36e-06	5.67e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	2.35e-06	5.65e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.34e-06	5.63e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.33e-06	5.61e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PTEN—kidney cancer	2.33e-06	5.6e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PTEN—kidney cancer	2.32e-06	5.59e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MYC—kidney cancer	2.32e-06	5.59e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.32e-06	5.58e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.3e-06	5.55e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.3e-06	5.54e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.29e-06	5.52e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.28e-06	5.49e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	2.27e-06	5.47e-05	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—TP53—kidney cancer	2.27e-06	5.46e-05	CbGpPWpGaD
Risperidone—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.27e-06	5.46e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.26e-06	5.45e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.25e-06	5.42e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MYC—kidney cancer	2.24e-06	5.39e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	2.23e-06	5.37e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MYC—kidney cancer	2.23e-06	5.37e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—PIK3CA—kidney cancer	2.21e-06	5.32e-05	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—PIK3CA—kidney cancer	2.2e-06	5.3e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.2e-06	5.29e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.2e-06	5.29e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.19e-06	5.28e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.19e-06	5.28e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.19e-06	5.27e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—PIK3CA—kidney cancer	2.18e-06	5.25e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.18e-06	5.25e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.18e-06	5.23e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MYC—kidney cancer	2.17e-06	5.22e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—KRAS—kidney cancer	2.15e-06	5.16e-05	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—TP53—kidney cancer	2.14e-06	5.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.14e-06	5.15e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.13e-06	5.14e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	2.12e-06	5.11e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.12e-06	5.1e-05	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—TP53—kidney cancer	2.11e-06	5.08e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.1e-06	5.06e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.1e-06	5.05e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.09e-06	5.03e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.08e-06	5.01e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.07e-06	4.98e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.06e-06	4.96e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.06e-06	4.96e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.02e-06	4.87e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTGS2—kidney cancer	2.01e-06	4.84e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—KRAS—kidney cancer	2e-06	4.82e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK3—kidney cancer	1.99e-06	4.79e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK3—kidney cancer	1.99e-06	4.78e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.97e-06	4.75e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	1.97e-06	4.74e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MYC—kidney cancer	1.97e-06	4.74e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.95e-06	4.69e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MYC—kidney cancer	1.94e-06	4.66e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MYC—kidney cancer	1.93e-06	4.65e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—MAPK1—kidney cancer	1.93e-06	4.63e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.91e-06	4.61e-05	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—TP53—kidney cancer	1.91e-06	4.59e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	1.9e-06	4.58e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.9e-06	4.56e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—MAPK1—kidney cancer	1.89e-06	4.56e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTGS2—kidney cancer	1.89e-06	4.56e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	1.89e-06	4.56e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—MAPK1—kidney cancer	1.89e-06	4.55e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.86e-06	4.46e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	1.84e-06	4.43e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—TP53—kidney cancer	1.84e-06	4.43e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—TP53—kidney cancer	1.83e-06	4.41e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—KRAS—kidney cancer	1.82e-06	4.38e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.81e-06	4.36e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.81e-06	4.36e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—KRAS—kidney cancer	1.79e-06	4.31e-05	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.79e-06	4.3e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—KRAS—kidney cancer	1.79e-06	4.3e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—TP53—kidney cancer	1.78e-06	4.29e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.76e-06	4.24e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PTEN—kidney cancer	1.75e-06	4.22e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.75e-06	4.22e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.75e-06	4.22e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.72e-06	4.15e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—PIK3CA—kidney cancer	1.67e-06	4.02e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PTEN—kidney cancer	1.65e-06	3.98e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.64e-06	3.96e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.64e-06	3.95e-05	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.64e-06	3.94e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.63e-06	3.92e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—TP53—kidney cancer	1.62e-06	3.89e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.61e-06	3.87e-05	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—TP53—kidney cancer	1.59e-06	3.83e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—TP53—kidney cancer	1.59e-06	3.82e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.56e-06	3.75e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—POMC—kidney cancer	1.55e-06	3.74e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.5e-06	3.6e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.45e-06	3.48e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.24e-06	2.98e-05	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.24e-06	2.98e-05	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.17e-06	2.8e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PTEN—kidney cancer	1.08e-06	2.6e-05	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.62e-07	1.83e-05	CbGpPWpGaD
